Dr Sanjeev Panchal
-
AstraZeneca receives CDSCO approval for Tremelimumab combination in India
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India…
Read More » -
AstraZeneca brings rare disease therapy for Indian patients
Receives regulatory approval for its molecule ‘Selumetinib’ in India AstraZeneca India announced its entry into rare disease therapy in India.…
Read More » -
India-Sweden Healthcare Innovation Centre, DHS Jammu integrate Qure.ai’s smart AI tech to detect lung cancer
Qure.ai is scaling up the integration of its AI-powered chest x-ray interpretation tool that can benefit the early and easy…
Read More »
